Lab
Laboratory Medicine Services Incorporated
Laboratory Medicine Services Incorporated was paid $621K by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 14% of everything it billed.
33Billing provider infoLABORATORY MEDICINE SERVICES INCORPORATED
CIDRA, PR 00739
CIDRA, PR 00739
33aNPI1407157704assigned 11/03/2010
33bProvider typeClinical Medical Laboratory
28Total paid$621K
24GClaims43,698
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#212 of 777
Median peer was paid$278K
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,855 | $27K | |
| 2019 | 3,202 | $29K | |
| 2020 | 5,125 | $77K | |
| 2021 | 9,175 | $175K | |
| 2022 | 7,992 | $132K | |
| 2023 | 8,491 | $100K | |
| 2024incomplete | 6,858 | $82K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 14% | 4,917 | 4,480 | $90K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 13% | 1,892 | 1,686 | $81K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12% | 2,956 | 2,564 | $71K |
| 80061 | Lipid panel | 11% | 4,616 | 4,197 | $69K |
| 80053 | Comprehensive metabolic panel | 9.1% | 4,817 | 4,411 | $56K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 8.3% | 1,017 | 929 | $51K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.9% | 6,089 | 5,502 | $43K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.6% | 1,044 | 962 | $29K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.2% | 2,529 | 2,340 | $26K |
| 81000 | 2.9% | 5,178 | 4,651 | $18K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.6% | 712 | 673 | $16K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 2,274 | 2,067 | $10K |
24 more codes
| 87400 | <1% | 277 | $6K | |
| 86738 | <1% | 431 | $5K | |
| 86328 | <1% | 273 | $5K | |
| 82043 | <1% | 978 | $5K | |
| 82274 | <1% | 324 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 232 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 80 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 127 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 105 | $3K |
| 85027 | <1% | 495 | $3K | |
| 84439 | <1% | 324 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 278 | $3K |
| 84153 | <1% | 141 | $2K | |
| 84436 | <1% | 375 | $2K | |
| 84479 | <1% | 308 | $2K | |
| 87088 | <1% | 157 | $2K | |
| 86592 | <1% | 337 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 73 | $537.76 |
| 82607 | <1% | 37 | $508.15 | |
| 82570 | <1% | 52 | $259.86 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 12 | $179.87 |
| 85651 | <1% | 31 | $103.93 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 43 | $0.03 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 167 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIMARDO-DEFENDINI, DEBORA (DIRECTOR/OWNER)
| Provider | Location | Paid |
|---|---|---|
| Santa Ana Laboratory Services Incorporated | Bayamon, PR | $32K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.